Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-10T15:08:57.215Z Has data issue: false hasContentIssue false

Quantitative analyses of complex pharmaceutical mixtures by the Rietveld method

Published online by Cambridge University Press:  05 March 2012

Sampath S. Iyengar*
Affiliation:
College of Pharmacy, 308 Harvard Street SE, University of Minnesota, Minneapolis, Minnesota 55455
Neelima V. Phadnis*
Affiliation:
College of Pharmacy, 308 Harvard Street SE, University of Minnesota, Minneapolis, Minnesota 55455
Raj Suryanarayanan*
Affiliation:
College of Pharmacy, 308 Harvard Street SE, University of Minnesota, Minneapolis, Minnesota 55455
*
a)Also at: Technology of Materials, 2922 De la Vina Street, Suite C, Santa Barbara, CA 93105.
b)Current address: SmithKline Beecham Consumer Healthcare, 1500 Littleton Road, Parsippany, NJ 07054.
c)Author to whom correspondence should be addressed; electronic mail: surya001@tc.umn.edu

Abstract

The object was to perform simultaneous quantitative analyses of complex pharmaceutical solid mixtures by the Rietveld method. Mixtures consisting of anhydrous β-carbamazepine, anhydrous α-carbamazepine, and carbamazepine dihydrate were chosen as the model system. Lithium fluoride was used as the internal standard. Mixtures of various compositions were prepared and subjected to X-ray powder diffractometry (XRD). The XRD pattern of each mixture was analyzed by the Rietveld method and at the end of the refinement, the goodness of fit was evaluated. When the analyte concentration was high (≥20%), the relative error in the determination was <±5%. The detection of analyte was possible even when its concentration was low (<1% w/w). A unique advantage of the method is that it enables simultaneous quantitative analyses of multiple phases without the requirement of “standard curves.” © 2001 International Centre for Diffraction Data.

Type
Technical Articles
Copyright
Copyright © Cambridge University Press 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anwar, J. (1993). “Analysis of Time-resolved Powder Diffraction Data using a Pattern-decomposition Method with Restraints,” J. Appl. Crystallogr. JACGAR 26, 413421. acr, JACGAR CrossRefGoogle Scholar
Bish, D. L., and Post, J. E. (1993). “Quantitative Mineralogical Analysis Using the Rietveld Full-pattern Fitting Method,” Am. Mineral. AMMIAY 78, 932940. amn, AMMIAY Google Scholar
Dugue, J., Ceolin, R., Rouland, J. C., and Lepage, F. (1991). “Polymorphism of Carbamazepine: Solid-state Studies on Carbamazepine Dihydrate,” Pharm. Acta Helv. PAHEAA 66, 307310., PAHEAA Google ScholarPubMed
Himes, V. L., Mighell, A. D., and De Camp, W. H. (1981). “Structure of Carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide,Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. ACBCAR 37, 22422245. acb, ACBCAR CrossRefGoogle Scholar
Howard, S., and Preston, K. D. (1989). “Profile Fitting of Powder Diffraction Patterns,” in Modern Powder Diffraction, edited by D. L. Bish and J. E. Post (The Mineralogical Society of America, Washington, DC) pp. 217–275.Google Scholar
Iyengar, S. S. (1994). “High Temperature X-ray Diffraction Analysis of Selected Ceramic Mixtures,” Powder Diffr. PODIE2 9, 3843. pdj, PODIE2 CrossRefGoogle Scholar
Iyengar, S. S., and Percec, S. (1994). “Rietveld Analysis of High Density Polyethylene,” Powder Diffr. PODIE2 9, 217220. pdj, PODIE2 CrossRefGoogle Scholar
Kaneniwa, N., Yamaguchi, T., Watari, N., and Otsuka, M. (1984). “Hygroscopicity of Carbamazepine Crystalline Powders,” Yakugaku Zasshi YKKZAJ 104, 184190., YKKZAJ CrossRefGoogle ScholarPubMed
Klug, H. P., and Alexander, L. E. (1974). X-ray Diffraction Procedures For Polycrystalline And Amorphous Materials, 2nd ed. (Wiley, New York).Google Scholar
Lefebvre, C., Guyot-Hermann, A. M., Draguet-Brughmans, M., Bouche, R., and Guyot, J. C. (1986). “Polymorphic Transitions of Carbamazepine during Grinding and Compression,” Drug Dev. Ind. Pharm. DDIPD8 12, 19131927. ddi, DDIPD8 CrossRefGoogle Scholar
Lowes, M. M., Caira, M. R., Lotter, A. P., and Van Der Watt, J. G. (1987). “Physicochemical Properties and X-ray Structural Studies of the Trigonal Polymorph of Carbamazepine,” J. Pharm. Sci. JPMSAE 76, 744752. jmk, JPMSAE CrossRefGoogle ScholarPubMed
PDF-2 (1996). International Centre for Diffraction Data, Newtown Square, PA.Google Scholar
Rietveld, H. M. (1969). “A Profile Refinement Method for Nuclear and Magnetic Structures,” J. Appl. Crystallogr. JACGAR 2, 6571. acr, JACGAR CrossRefGoogle Scholar
Smith, D. K., Johnson, G. G. Jr, Scheible, A., and Wims, A. M. (1988). “Use of Full Diffraction Spectra, both Experimental and Calculated in Quantitative Powder Diffraction Analysis,” Aust. J. Phys. AUJPAS 41, 311321. auj, AUJPAS CrossRefGoogle Scholar
Suryanarayanan, R. (1989). “Determination of the Relative Amounts of Anhydrous Carbamazepine (C15H12N2O) and Carbamazepine Dihydrate (C15H12N2O⋅2H2O) in a Mixture by Powder X-ray Diffractometry,” Phys. Res. PHSREL 6, 10171024., PHSREL Google Scholar
Suryanarayanan, R. (1990). “Determination of the Relative Amounts of α-carbamazepine and β-carbamazepine in a Mixture by Powder X-ray Diffractometry,” Powder Diffr. PODIE2 5, 155159. pdj, PODIE2 CrossRefGoogle Scholar
Suryanarayanan, R. (1995). “Powder X-ray Diffractometry,” in Physical Characterization of Pharmaceutical Solids, edited by H. G. Brittain (Marcel Dekker, New York), pp. 187–221.Google Scholar
The United States Pharmacopeia 24/The National Formulary 19 (1999), United States Pharmacopeial Convention (Rockville, MD).Google Scholar
Young, R. A., Sakthivel, A., Moss, T. S., and Paiva-Santos, C. O. (1995). “DBWS-9411-an Upgrade of the DBWS*.* Programs for Rietveld Refinement with PC and Main-frame Computers,” J. Appl. Crystallogr. JACGAR 28, 366367. acr, JACGAR CrossRefGoogle Scholar
Young, W. W. L., and Suryanarayanan, R. (1990). “Kinetics of Transition of Anhydrous Carbamazepine to Carbamazepine Dihydrate in Aqueous Suspensions,” J. Pharm. Sci. JPMSAE 80, 496500. jmk, JPMSAE CrossRefGoogle Scholar